Article info
Editorial
Therapeutic innovation in adult-onset Still’s disease (and other rare inflammatory disorders): how to secure evidence-based medicine?
- Correspondence to Dr Philippe Guilpain, Department of internal medicine, Multi-Organic Diseases, St Eloi Hospital, CHRU de Montpellier, Montpellier, F-34295, France; p-guilpain{at}chu-montpellier.fr
Citation
Therapeutic innovation in adult-onset Still’s disease (and other rare inflammatory disorders): how to secure evidence-based medicine?
Publication history
- Received March 29, 2018
- Revised May 14, 2018
- Accepted May 15, 2018
- First published June 2, 2018.
Online issue publication
August 02, 2020
Article Versions
- Previous version (2 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.